The expression of functional SGLT1 in human hearts was already demonstrated by von Lewinsky et al. [40], that reported that SGLT1 contributes to the positive inotropic effect exerted by insulin in patients with end-stage HF. This evidence concerns the gene SLC5A1 and hydrops fetalis.